Product Images Contrave Extended-release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Contrave Extended-release NDC 50090-2945 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - contrave er 01

Table 1 - contrave er 01

Naltrexone Hydrochloride Chemical Structure - contrave er 02

Naltrexone Hydrochloride Chemical Structure - contrave er 02

Bupropion Hydrochloride Chemical Structure - contrave er 03

Bupropion Hydrochloride Chemical Structure - contrave er 03

Figure 1 - contrave er 04

Figure 1 - contrave er 04

This appears to be a graph that shows weight change from baseline over time in weeks for a group taking a weight loss drug called CONTRAVE32/360 and a group taking a placebo. The data is labeled with time points in weeks and a percentage change in weight from baseline. The abbreviation "ITT-LOCF" likely refers to the statistical method used to analyze the data.*

Figure 1 - contrave er 05

Figure 1 - contrave er 05

This appears to be a chart showing weight change percentages of individuals taking CONTRAVE32360 medication versus a placebo over a course of 52 weeks. The graph includes data points at weeks 12, 16, 20, 24, 28, 32, 36, 40, 44, 48 and 52. The abbreviations ITT-LOCF appears to be related to statistical analysis.*

Figure 1 - contrave er 06

Figure 1 - contrave er 06

Label Image - lbl500902945

Label Image - lbl500902945

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.